Nanomedicine captures cardiovascular disease.
Mulder
Willem J M
WJ
Fayad
Zahi A
ZA
D000800:Angioplasty, Balloon / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D050197:Atherosclerosis / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D003251:Constriction, Pathologic / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology; D005263:Femoral Artery / Q000187:drug effects / Q000473:pathology; D006801:Humans; D050997:Nanomedicine / Q000379:methods*; D053758:Nanoparticles / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D020123:Sirolimus